GenXPro has organized the kick-off meeting for EUREKA Innovation collaboration with partners Avidin and Steinbeis-Innovationszentrum Zellkulturtechnik (SIZ) in Frankfurt The special German-Hungarian collaborative program’s
AVIDIN synthetized Mannich curcuminoids, C142 and C150 showed potent anti-inflammatory properties, Special focus on …
Enantiomers of lead compounds for neurodegenerative diseases has been granted in the U.S.A. Avidin’s patent, entitled ‘Enantiomers of 8-Hydroxy Quinoline derivatives and the synthesis’ was
Avidin’s CEO László Puskás and Head of International Relations Klára Kitajka are participating at BIO 2019 …
Poster in the 14th international conference on Alcheimer’s and Parkinson’s diseases and related neurological disorders
In the last decade, oxidative stress has emerged as a key factor in many diseases including cardiovascular diseases, cancer, atherosclerosis, diabetes, arthritis, lung, kidney, liver disease, neurodegenerative disorders, and neuropathy.
AVIDIN’s CEO László Puskás was recently awarded with the Dénes Gábor Prize…
Genetic predisposition and life style management contribute to the development of type 2 diabetes mellitus (T2DM).
Novel 8-hydroxyquinoline pharmacophore scaffold was synthetized by Avidin’s Medicinal Pharmacolgy department which has been shown to possess a range of activities as metal chelation, enzyme inhibition, cytotoxicity